Latest Regulatory News

Regener8 Resources has acquired 100% of the Srebrenica North Project, a polymetallic silver-lead-zinc asset in a historically rich European mining district, positioning itself amid active regional exploration and production hubs.

Freehill Mining has raised $1.5 million through a discounted share placement to fund exploration of copper-gold projects in Chile and expand its processing capacity.

New Hope Corporation has extended its on-market share buy-back program to March 2027, reinforcing its commitment to capital management and shareholder value enhancement. The continuation remains subject to market conditions and company discretion.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

Reef Casino Trust has issued a second supplementary target’s statement as the takeover bid by Iris Cairns Property Pty Ltd extends to August 2026 due to delayed casino licensing approvals. The board maintains its recommendation for unitholders to accept the offer, pending regulatory outcomes and expert advice.

Santos Limited has updated details on the currency exchange rates used to convert its 2025 final dividend, offering shareholders multiple payment currency options ahead of the March payout.

Identitii Limited’s ID8N securities have been reinstated to trading following the close of its recent rights issue and the resolution of a Takeovers Panel application.

Northern Minerals has withdrawn its Extraordinary General Meeting and obtained a court order to defer its 2025 AGM until June 30, 2026, allowing more time for regulatory review. This move supports progress toward a key investment decision for its Browns Range rare earths project.

H3 Energy’s latest technical review reveals promising signs for commercial gas flow at the Warro Field, setting the stage for a targeted appraisal campaign.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals is seeking a re-examination of the European Medicines Agency’s refusal to approve trofinetide for Rett syndrome, aiming to overturn the setback and bring the treatment to European patients.

Magellan Financial Group has successfully raised $130 million through an institutional placement to support its strategic merger with Barrenjoey Capital Partners, with a $20 million share purchase plan also announced for existing shareholders.

Lindian Resources has executed a binding agreement to acquire full ownership of a rare earths processing facility in Kazakhstan, marking a strategic shift from concentrate production to higher-value Mixed Rare Earth Carbonate (MREC) output by late 2026.